Bionano Genomics, Inc. BNGO 深 沪
交易中 05-15 10:43:46 美东时间
1.1799
-0.010
-0.85%
华盛通- 最 高1.19
- 今 开1.19
- 成交量 6.10万股
- 最 低 1.16
- 昨 收 1.19
- 总市值 1308.70万
- 52周最高 5.50
- 市盈率 静 --
- 换手率 0.55%
- 52周最低 1.06
- 委 比 24.39%
- 总股本 1109.16万
- 历史最高 9414.00
- 量 比 1.84
- 振 幅 2.52%
- 历史最低 1.06
- 每 手 1
- 风险率 1.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Bionano Genomics (NASDAQ:BNGO) reported first-quarter financial results on Wedn...
05-14 05:10
Bionano Genomics Q1 EPS $(0.76) Beats $(0.95) Estimate, Sales $6.687M Beat $6.567M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.95) by 20 percent. This is a 33.91 percent increase over losses of $(1.15) per share from the
05-14 04:11
Bionano Genomics Sees Q2 Sales $7.500M-$7.800M vs $7.520M Est
Bionano Genomics (NASDAQ:BNGO) sees Q2 sales of $7.500 million-$7.800 million vs $7.520 million analyst estimate.
05-14 04:08
Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.
05-14 04:07
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Bionano Genomics Appoints Chairman Al Luderer Interim President, CEO, Effective Immediately
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president and chief executive officer, effective May 5, 2026. Dr. Luderer
05-07 04:49
美股大行评级 | 大摩上调哔哩哔哩目标价从25美元升至31美元；大砍近50%！汇丰下调耐克目标价从90美元降至48美元
今日重点评级关注：HC Wainwright & Co.：维持Solaris Resources"买入"评级，目标价从16美元升至18美元；Leerink Partners：维持Spyre Therapeutics"跑赢大市"评级，目标价从49美元升至106美元
04-14 10:44
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $7 to $6.
04-13 18:54
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story
Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings report.
03-24 04:50
Earnings Scheduled For March 23, 2026
Companies Reporting Before The Bell • Avalo Therapeutics (NASDAQ:AVTX) is likel...
03-23 19:11
